{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:08:45Z","timestamp":1778638125464,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ucl.2025.09.012","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:45:50Z","timestamp":1762206350000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of Pelvic Lymph Node Dissection in the Surgical Treatment of Clinically Localized Prostate Cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Maxwell","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim A.","family":"Touijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10437","key":"10.1016\/j.ucl.2025.09.012_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/JU.0000000000000504","article-title":"Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D\u2019amico intermediate and high risk prostate cancer treated with radical prostatectomy: a multi-institutional study","volume":"203","author":"Preisser","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.012_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-1596-1-4","article-title":"Prognostic factors in prostate cancer","volume":"1","author":"Buhmeida","year":"2006","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.012_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.012_bib9","series-title":"StatPearls","article-title":"Anatomy, abdomen and pelvis, prostate","author":"Singh","year":"2025"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clgc.2013.04.031","article-title":"A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques","volume":"11","author":"Swanson","year":"2013","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2214\/AJR.20.22997","article-title":"Understanding the lymphatics: an updated review of the N category of the AJCC 8th edition for urogenital cancers","volume":"217","author":"Pedersen","year":"2021","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib12","first-page":"135","article-title":"Pathways of lymphatic spread in male urogenital pelvic malignancies","volume":"31","author":"Pa\u00f1o","year":"2011","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12957-024-03344-2","article-title":"The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review","volume":"22","author":"Dong","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.012_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ctrv.2015.10.005","article-title":"Definition of lymph node areas for radiotherapy of prostate cancer: a critical literature review by the French genito-urinary group and the French association of urology (GETUG-AFU)","volume":"41","author":"Sargos","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2012.06.057","article-title":"Mapping of pelvic lymph node metastases in prostate cancer","volume":"63","author":"Joniau","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2025.09.012_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fsurg.2018.00052","article-title":"Difference in frequency and distribution of nodal metastases between intermediate and high risk prostate cancer patients: results of a superextended pelvic lymph node dissection","volume":"5","author":"Roscigno","year":"2018","journal-title":"Front Surg"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.012_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12957-023-02932-y","article-title":"Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis","volume":"21","author":"Zhang","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.012_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.urolonc.2012.04.021","article-title":"Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America","volume":"31","author":"Touijer","year":"2013","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CU9.0000000000000132","article-title":"Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries","volume":"16","author":"Flammia","year":"2022","journal-title":"Curr Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib23","doi-asserted-by":"crossref","first-page":"81.e17","DOI":"10.1016\/j.urolonc.2017.10.022","article-title":"Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D\u2019Amico lymph node invasion risk stratification","volume":"36","author":"Leyh-Bannurah","year":"2018","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00345-018-2195-9","article-title":"Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer","volume":"36","author":"Borkowetz","year":"2018","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0022-5347(05)00685-3","article-title":"The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer","volume":"175","author":"Masterson","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib26","first-page":"5585","article-title":"Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram","volume":"18","author":"Kazzazi","year":"2011","journal-title":"Can J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5489\/cuaj.10185","article-title":"Why all prostate cancer surgery should include an adequate lymph node dissection","volume":"4","author":"Siemens","year":"2010","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","article-title":"Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis","volume":"167","author":"Heidenreich","year":"2002","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.012_bib29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1442-2042.2012.02993.x","article-title":"Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer","volume":"19","author":"Abdollah","year":"2012","journal-title":"Int J Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2025.09.012_bib30","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/01.ju.0000137817.56888.d1","article-title":"Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping","volume":"172","author":"Bochner","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib31","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.juro.2012.01.079","article-title":"Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series","volume":"187","author":"Godoy","year":"2012","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/JU.0000000000002439","article-title":"Prevalence of high-risk prostate cancer metastasis to cloquet\u2019s ilioinguinal lymph node","volume":"207","author":"Plata Bello","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib34","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/annonc\/mdt120","article-title":"Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center","volume":"24","author":"Abdollah","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clon.2019.12.001","article-title":"The horse is at the stable door: management of N1M0 prostate cancer","volume":"32","author":"Thiruthaneeswaran","year":"2020","journal-title":"Clin Oncol R Coll Radiol G B"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib36","first-page":"112","article-title":"The importance of pelvic lymph node dissection in men with clinically localized prostate cancer","volume":"8","author":"Allaf","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.ucl.2025.09.012_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-233","article-title":"Radical prostatectomy and pelvic lymph node dissection in kaiser permanente southern California: 15-year experience","volume":"23","author":"Banapour","year":"2019","journal-title":"Perm J"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.09.039","article-title":"Utility of choline positron emission tomography\/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis","volume":"63","author":"Evangelista","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib39","first-page":"680","article-title":"Pelvic lymph node dissection in prostate and bladder cancers","volume":"74","author":"Rocco","year":"2022","journal-title":"Minerva Urol Nephrol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.012_bib40","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2017.06.062","article-title":"Contemporary patterns of care and outcomes of men found to have lymph node metastases at the time of radical prostatectomy","volume":"198","author":"Zareba","year":"2017","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JU.0000000000004587","article-title":"Pelvic lymph node dissection in prostate cancer: is it really necessary? A multicentric longitudinal study assessing oncological outcomes in patients with prostate cancer undergoing pelvic lymph node dissection vs radical prostatectomy only","volume":"214","author":"Furrer","year":"2025","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.ucl.2025.09.012_bib43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2017.74.2940","article-title":"Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer","volume":"36","author":"Spratt","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ucl.2025.09.012_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512508","article-title":"Can we predict prostate cancer metastasis based on biomarkers? Where are we now?","volume":"24","author":"San Francisco","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00345-014-1351-0","article-title":"No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer","volume":"33","author":"Boehm","year":"2015","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.ucl.2025.09.012_bib47","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00345-017-2079-4","article-title":"Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment","volume":"35","author":"Mandel","year":"2017","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-013-1056-9","article-title":"Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy","volume":"31","author":"Liss","year":"2013","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12894-020-00601-w","article-title":"Urinary continence outcomes of four years of follow-up and predictors of early and late urinary continence in patients undergoing robot-assisted radical prostatectomy","volume":"20","author":"Li","year":"2020","journal-title":"BMC Urol"},{"issue":"23","key":"10.1016\/j.ucl.2025.09.012_bib50","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.3390\/cancers14235803","article-title":"Pelvic lymphadenectomy may not improve biochemical recurrence-free survival in patients with prostate cancer treated with robot-assisted radical prostatectomy in Japan (the MSUG94 Group)","volume":"14","author":"Namiki","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.012_bib52","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1245\/s10434-017-5822-6","article-title":"Extended versus standard pelvic lymph node dissection in radical prostatectomy on oncological and functional outcomes: a systematic review and meta-analysis","volume":"24","author":"Choo","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ucl.2025.09.012_bib53","first-page":"1092","article-title":"Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?","volume":"20","author":"Mitsuzuka","year":"2013","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib54","first-page":"104","article-title":"Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer","volume":"12","author":"Furubayashi","year":"2020","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","article-title":"Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive systematic review and meta-analysis","volume":"4","author":"Cacciamani","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib56","article-title":"747 prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer \u2013 first descriptive results (SEAL, AUO AP 55\/09)","volume":"13","author":"Schwerfeld-Bohr","year":"2014","journal-title":"Eur Urol Suppl"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5347(05)64055-4","article-title":"Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer","volume":"169","author":"Clark","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib58","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.5489\/cuaj.647","article-title":"The deep vein thrombosis caused by lymphocele after endoscopic extraperitoneal radical prostatectomy and pelvic lymph node dissection","volume":"5","author":"Park","year":"2011","journal-title":"Can Urol Assoc J J Assoc Urol Can"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.juro.2014.08.091","article-title":"Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection","volume":"193","author":"Tyritzis","year":"2015","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2020.05.001","article-title":"Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial","volume":"78","author":"Patel","year":"2020","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib61","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00345-015-1699-9","article-title":"Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis","volume":"34","author":"Hatzichristodoulou","year":"2016","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/iju.15119","article-title":"Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy","volume":"30","author":"Lee","year":"2023","journal-title":"Int J Urol"},{"key":"10.1016\/j.ucl.2025.09.012_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110110","article-title":"Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer","volume":"147","author":"Valentin","year":"2022","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib65","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib66","first-page":"96","article-title":"Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET\/CT on radiotherapy decision-making in patients with node-positive disease","volume":"24","author":"Furman","year":"2024","journal-title":"Cancer Imaging Off Publ Int Cancer Imaging Soc"},{"issue":"11","key":"10.1016\/j.ucl.2025.09.012_bib67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.crad.2015.06.093","article-title":"PI-RADS version 2: what you need to know","volume":"70","author":"Barrett","year":"2015","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2478\/raon-2019-0021","article-title":"Multiparametric MRI - local staging of prostate cancer and beyond","volume":"53","author":"Caglic","year":"2019","journal-title":"Radiol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40644-016-0068-2","article-title":"Prostate MRI based on PI-RADS version 2: how we review and report","volume":"16","author":"Steiger","year":"2016","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ucl.2025.09.012_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.831429","article-title":"PSMA PET in imaging prostate cancer","volume":"12","author":"Tsechelidis","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib72","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer-a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib73","first-page":"10","article-title":"PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review","volume":"20","author":"Petersen","year":"2020","journal-title":"Cancer Imaging Off Publ Int Cancer Imaging Soc"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","volume":"5","author":"Stabile","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.012_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5534\/wjmh.180124","volume":"38","author":"Wu","year":"2020","journal-title":"World J Mens Health"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib76","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12885-020-07192-7","article-title":"Clinical impact of PSMA PET\/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study","volume":"20","author":"Donswijk","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.semnuclmed.2023.07.001","article-title":"PSMA PET\/CT for primary staging of prostate cancer - an updated overview","volume":"54","author":"Jochumsen","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ucl.2025.09.012_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2025.01.015","article-title":"Diagnostic accuracy of prostate-specific membrane antigen positron emission tomography\/computed tomography for primary lymph node staging before radical prostatectomy","author":"Incesu","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (partin tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"issue":"18","key":"10.1016\/j.ucl.2025.09.012_bib80","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of prostate-specific antigen, clinical stage, and gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.012_bib81","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2006.01.043","article-title":"Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy","volume":"49","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.012_bib82","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/01.ju.0000091805.98960.13","article-title":"A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer","volume":"170","author":"Cagiannos","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.012_bib83","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bju.12280","article-title":"Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era","volume":"113","author":"Kim","year":"2014","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0090-4295(00)01039-6","article-title":"Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer","volume":"57","author":"Batuello","year":"2001","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.012_bib85","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.012_bib86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:05:30Z","timestamp":1765289130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0094014325000953"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.012","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Pelvic Lymph Node Dissection in the Surgical Treatment of Clinically Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}